Priming T-Cells: Do We Understand the Strategies?

Access Course


0bd87a52-42d9-41ee-8176-461723604db4.jpgThree articles examine the role of T cells in the anticancer immune response and how they are being used in therapy.

This activity is intended for hematologists and oncologists, pulmonologists and dermatologists.The goal of this activity is to explore advances being made in the harnessing of T cells for cancer immunotherapies.



Approximate Time to Complete: 1.25 hours


Credit Available: Sept. 15, 2016- Sept. 15, 2017


Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Determine how T-cell populations function under normal homeostasis
  • Identify how T-cell populations can be manipulated to kill cancer cells